These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11999190)

  • 21. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix.
    Nagaki M; Miki K; Kim YI; Ishiyama H; Hirahara I; Takahashi H; Sugiyama A; Muto Y; Moriwaki H
    Dig Dis Sci; 2001 May; 46(5):1046-56. PubMed ID: 11341648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems.
    Tsiaoussis J; Newsome PN; Nelson LJ; Hayes PC; Plevris JN
    Liver Transpl; 2001 Jan; 7(1):2-10. PubMed ID: 11150414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
    van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
    J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use.
    Kobayashi N; Okitsu T; Nakaji S; Tanaka N
    J Artif Organs; 2003; 6(4):236-44. PubMed ID: 14691665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
    Shinoda M; Tilles AW; Kobayashi N; Wakabayashi G; Takayanagi A; Totsugawa T; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Tanaka N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
    J Surg Res; 2007 Jan; 137(1):130-40. PubMed ID: 17081566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth and metabolic activity of immortalized porcine hepatocytes in extracorporeal hollow-fiber liver assist devices.
    Liu J; Jauregui HO; Faris RA; Santangini HA; Trenkler DM; Silva PG; Garcia KM
    Artif Organs; 2001 Jul; 25(7):539-45. PubMed ID: 11493274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of induced pluripotent stem cell derived hepatocytes.
    Hannoun Z; Steichen C; Dianat N; Weber A; Dubart-Kupperschmitt A
    J Hepatol; 2016 Jul; 65(1):182-199. PubMed ID: 26916529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver.
    Poyck PP; Hoekstra R; van Wijk AC; Attanasio C; Calise F; Chamuleau RA; van Gulik TM
    Liver Transpl; 2007 Apr; 13(4):589-98. PubMed ID: 17394165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioartificial liver: its pros and cons.
    Chamuleau RA; Poyck PP; van de Kerkhove MP
    Ther Apher Dial; 2006 Apr; 10(2):168-74. PubMed ID: 16684219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First report of cryopreserved human hepatocytes based bioartificial liver successfully used as a bridge to liver transplantation.
    Baccarani U; Donini A; Sanna A; Risaliti A; Cariani A; Nardo B; Cavallari A; Martinelli G; Ridolfi L; Bellini G; Scalamogna M; Bresadola F
    Am J Transplant; 2004 Feb; 4(2):286-9. PubMed ID: 14974954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HepaRG cell line is suitable for bioartificial liver application.
    Hoekstra R; Nibourg GA; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Lamers WH; Elferink RP; Chamuleau RA
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1483-9. PubMed ID: 21726661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytes.
    Wang Y; Zheng Q; Sun Z; Wang C; Cen J; Zhang X; Jin Y; Wu B; Yan T; Wang Z; Gu Q; Lv X; Nan J; Wu Z; Sun W; Pan G; Zhang L; Hui L; Cai X
    Cell Stem Cell; 2023 May; 30(5):617-631.e8. PubMed ID: 37059100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism.
    Wang Y; Chang L; Zhai J; Wu Q; Wang D; Wang Y
    J Cell Mol Med; 2017 Dec; 21(12):3214-3223. PubMed ID: 28557353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic considerations in development of a bioartificial liver.
    Iwata H; Ueda Y
    Clin Pharmacokinet; 2004; 43(4):211-25. PubMed ID: 15005636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes.
    Nguyen TH; Mai G; Villiger P; Oberholzer J; Salmon P; Morel P; Bühler L; Trono D
    J Hepatol; 2005 Dec; 43(6):1031-7. PubMed ID: 16169114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines.
    Adam AAA; van der Mark VA; Donkers JM; Wildenberg ME; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    PLoS One; 2018; 13(4):e0193664. PubMed ID: 29672606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crucial roles of mesodermal cell lineages in a murine embryonic stem cell-derived in vitro liver organogenesis system.
    Ogawa S; Tagawa Y; Kamiyoshi A; Suzuki A; Nakayama J; Hashikura Y; Miyagawa S
    Stem Cells; 2005 Aug; 23(7):903-13. PubMed ID: 16043458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the next generation of bioartificial liver devices.
    Allen JW; Bhatia SN
    Semin Cell Dev Biol; 2002 Dec; 13(6):447-54. PubMed ID: 12468246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability.
    Flendrig LM; Chamuleau RA; Maas MA; Daalhuisen J; Hasset B; Kilty CG; Doyle S; Ladiges NC; Jörning GG; la Soe JW; Sommeijer D; te Velde AA
    J Hepatol; 1999 Feb; 30(2):311-20. PubMed ID: 10068112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life support of artificial liver: development of a bioartificial liver to treat liver failure.
    Kobayashi N
    J Hepatobiliary Pancreat Surg; 2009; 16(2):113-7. PubMed ID: 19110648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.